$PLMR (+0,86%)

Obvious successes

A transformation always involves risks, but Palomar is not just at the beginning of a transformation; it has long since proven that the strategic realignment is successful.

In each of the last three years, profits have jumped by more than 30 % and considerable growth is also expected in the future.

In the first quarter of the current financial year, sales (underwriting revenue) increased by 52% to USD 164.1 million.

Earnings climbed by as much as 72% to USD 1.87 per share, far exceeding expectations of USD 1.58.

As a result, Palomar raised its forecast for annual profit from USD 180 - 192 million to USD 186 - 200 million.

The share then reached a new all-time high of around USD 175 at the end of June and was then sold off - without any news, at least I couldn't find anything relevant.

Outlook and valuation

In the second quarter, sales (underwriting revenue) increased by 48 % to USD 181.6 million.

Earnings climbed by 41% to USD 1.76 per share, once again exceeding expectations of USD 1.68.

As a result, Palomar raised its forecast for net income from USD 186 - 200 million to USD 198 - 208 million.

As a result, the share price fell further and reached a low of USD 110. The share price currently stands at USD 120.86.

As profits are expected to jump by 41% to USD 7.20 per share in the current financial year, Palomar has a forward P/E of 16.8.

The Board of Directors has reacted to this and decided to buy back shares to the value of USD 150 million, which corresponds to around 5% of the market capitalization

Palomar share: chart from 20.08.2025, price: USD 120.86 - symbol: PLMR | Source: TWS

The long-term outlook was confirmed again at the Investor Day in March. Palomar is targeting a doubling of normalized net income to over USD 10 per share by 2027.

Source

https://www.lynxbroker.de/boerse/boerse-kurse/aktien/palomar-aktie/palomar-analyse/?a=3355991664&utm_medium=email&utm_source=newsletter&utm_campaign=newsletter-boersenblick&newsletter=true&mc-rss-cache-bypass=2025082106&goal=0_d93daae099-8a68287b7f-410756260#palomar-vom-erdbeben-spezialisten-zum-wachstumschampion

This week, I’ve implemented an investment plan that’s a bit more capital-intensive than in previous weeks, thanks to some extra income.

I’ve tried to take advantage of the correction in $PLMR (+0,86%) (my growth play in the insurance sector) and the decline following the capital increase at $AMP (-0,21%) (my speculative bet, which is becoming less and less speculative), as well as increasing my exposure to the company with the most solid and sustainable dividend in my portfolio, $G (-0,86%) .

The rest of my investments—in Sabre, Allianz, and Ping An—are simply part of a dynamic dollar-cost averaging (DCA) plan that I’ve already set up based on how their prices have changed since my last purchase.

And our portfolio value has now surpassed €1,000!

——

This week, I carried out a slightly more capital-intensive investment plan than in previous weeks, thanks to some extra income.

I took the opportunity to buy into the correction in Palomar Holdings (my growth play in the insurance sector) and the drop following Amper’s capital increase (my speculative pick, which is becoming less speculative over time), as well as to increase my weighting in Generali, the company with the most solid and consistent dividend in the portfolio.

The rest of the investments—in Sabre, Allianz, and Ping An—simply follow a dynamic DCA strategy I’ve set up in advance, based on how their prices change relative to my previous purchase.

And with this, our total portfolio value has already surpassed €1,000!

As I do every week, I’ve made new additions to my portfolio following my Dynamic Dollar-Cost Averaging (DCA) strategy through Trade Republic’s investment plan. Thus, I continue to apply equal parts method and discipline in the face of a volatile market, especially during a month marked by quarterly earnings releases and dividend payment dates.

Here are my purchases for the week:

• $2318 (-1,04%) (€5): The Chinese insurance sector remains under pressure from macroeconomic uncertainty and the slowdown in China’s real estate market. We took the opportunity to invest in Asia’s largest and most technologically advanced insurer.
• $SBRE (+0,92%) (€19): The company reported earnings this week. Analysts weren’t particularly impressed with the annual outlook, but the company continues to grow its market share and remains unique in its niche.
• $AMP (-0,21%) (€10): The stock continues to trade sideways and remains well below its target price. This month, we learned of the award of new international contracts.
• $PLMR (+0,86%) (€20): It’s holding steady at last week’s price, so why not increase my position in a company I believe in?
• $ALV (+1,47%) (€10): It’s in a support zone, and the company is a powerhouse. We need to stick to the plan.

See you on June 2!

—-

As I do every week, I’ve made new additions to my portfolio following my Dynamic Dollar-Cost Averaging (DCA) strategy through Trade Republic’s investment plan. This way, I continue to apply both method and discipline in a volatile market environment, especially during a month filled with quarterly earnings releases and ex-dividend dates.

Here are my purchases this week:

• $2318 (-1,04%) (5 €): The Chinese insurance sector remains under pressure due to macroeconomic uncertainty and the ongoing real estate slowdown. A good opportunity to invest in Asia’s largest and most tech-driven insurer.

• $SBRE (+0,92%) (19 €): Earnings were released this week. Analysts weren’t overly optimistic about the annual guidance, but the company continues to gain market share and remains strong in its niche.

• $AMP (-0,21%) (10 €): The stock remains range-bound and well below its target price. This month, the company secured new international contracts, which reinforces its growth potential.

• $PLMR (+0,86%) (20 €): The price remains unchanged from last week, so why not increase my exposure to a company I believe in?

• $ALV (+1,47%) L (10 €): Trading at a key support level. This company is a powerhouse—no reason to deviate from the plan.

See you on June 2nd!

Neither have I entered the world of torcaces, nor is it the name of a new memecoin. Today I started my journey with $PLMR (+0,86%) a US insurer specializing in natural catastrophes and other unusual risks. And it's not doing too badly:

• Combined ratio (return on premiums): 78% (from 100% it is a "loss").
• ROE of 17.46, the third highest in my portfolio.
• A growth growth, partly due to the fact that it does not pay dividends.
• EPS of 4.5.
• Price to book value ratio book value bad for my filter, but we assume: 5.78.

--

I haven't ventured into the world of wood pigeons, nor is this the name of a new memecoin. Today, I've started my position in $PLMR (+0,86%) a U.S. insurance company specialized in natural catastrophes and other uncommon risks. And it's actually doing quite well:

• Combined ratio (profitability relative to premiums): 78% (anything over 100% means underwriting losses)
• ROE of 17.46%, the third highest in my portfolio.
• Strong growthpartly driven by the fact that it doesn't pay dividends.
• EPS of 4.5
• The Price-to-Book ratio is a bit above my usual filter at 5.78, but I'm willing to accept it.